Patents by Inventor David William Harper
David William Harper has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 9657489Abstract: A structural support having fractal-stiffening and method of fabricating the support is presented where an optimized location of at least three nodes is predetermined prior to fabricating the structural support where a first set of webs is formed on one side of the support and joined to the nodes to form a first pocket region. A second set of webs is formed within the first pocket region forming a second pocket region where the height of the first set of webs extending orthogonally from the side of the support is greater than the second set of webs extending orthogonally from the support.Type: GrantFiled: June 15, 2015Date of Patent: May 23, 2017Assignee: The Boeing CompanyInventor: David William Harper
-
Publication number: 20160362905Abstract: A structural support having fractal-stiffening and method of fabricating the support is presented where an optimized location of at least three nodes is predetermined prior to fabricating the structural support where a first set of webs is formed on one side of the support and joined to the nodes to form a first pocket region. A second set of webs is formed within the first pocket region forming a second pocket region where the height of the first set of webs extending orthogonally from the side of the support is greater than the second set of webs extending orthogonally from the support.Type: ApplicationFiled: June 15, 2015Publication date: December 15, 2016Inventor: David William Harper
-
Publication number: 20090293733Abstract: Various forms of apparatus (1) for preparing and dispensing beverages, preferably based on coffee, can receive instructions from a customer and deliver the beverage automatically. The apparatus is preferably capable of fully automatic cleaning in a cleaning cycle in which a cleaning agent is flushed through the lines (62, 64), and the apparatus is preferably arranged to ensure that not only are the lines cleaned properly but that no cleaning agent can be dispensed. The apparatus includes a brewer assembly (78) having a chamber (81) in which freshly ground coffee can be introduced and either espresso or filter coffee can be automatically prepared by passing hot water through the chamber and removing the spent coffee grounds. The coffee may be stored as coffee beans in sealed containers (208) that can automatically be pierced to release the beans which are ground immediately before preparation of the beverage.Type: ApplicationFiled: February 28, 2006Publication date: December 3, 2009Applicant: COFFEE NATION LTD.Inventors: Scott Martin, Steve Irwin, Andrew Chi Wai Yau, David William Smith, Jake Philip Tuner, John McGarva, Patrick Sweeting, Simon James Naylor, David William Harper, David Bradshaw, Michael Robert Nelson, Martyn Dawes, Damyn James Musgrave
-
Patent number: 6218373Abstract: A method of treating a disease of condition administering topically to the skin or exposed tissue of a human, a dosage amount of a pharmaceutical composition, said dosage comprising a therapeutically effective amount of a drug to treat said disease or condition and a form of hyaluronic acid characterized in that the composition is immediately available to transport the drug percutaneously into the epidermis of the skin or exposed tissue to the site of trauma or pathology of the disease or condition to be treated.Type: GrantFiled: June 6, 1995Date of Patent: April 17, 2001Assignee: Hyal Pharmaceutical CorporationInventors: Rudolf Edger Falk, Samuel Simon Asculai, David Hochman, Don Purschke, Ehud Shmuel Klein, David William Harper
-
Patent number: 6140312Abstract: The invention relates to a method of rapidly transporting a drug to the epidermis and accumulating and maintaining the drug therein for a prolonged period of time comprising administration of a therapeutically efective non-toxic amount of the drug with an effective amount of hyaluronic acid.Type: GrantFiled: June 6, 1995Date of Patent: October 31, 2000Assignee: Hyal Pharmaceutical CorporationInventors: Rudolf Edger Falk, Samuel Simon Asculai, David Hochman, Don Purschke, Ehud Shmuel Klein, David William Harper
-
Patent number: 6136793Abstract: A method of treating a disease or condition comprising administering topically to the skin or exposed tissue of a human, a dosage amount of a pharmaceutical composition, said dosage comprising a therapeutically effective amount of a drug to treat said disease or condition and a form of hyaluronic acid characterized in that the composition is immediately available to transport the drug percutaneously into the epidermis of the skin or exposed tissue to the site of trauma or pathology of the disease or condition to be treated.Type: GrantFiled: June 6, 1995Date of Patent: October 24, 2000Assignee: Hyal Pharmaceutical CorporationInventors: Rudolf Edger Falk, Samuel Simon Asculai, David Hochman, Don Purschke, Ehud Shmuel Klein, David William Harper
-
Patent number: 6103704Abstract: A method of accumulating a drug and a form of hyaluronic acid in the skin and/or exposed tissue of a human includes topically administering a therapeutically effective dosage amount of a formulation which comprises at least 5 mg/cm.sup.2 of the form of hyaluronic acid and a therapeutically effective amount of the drug.Type: GrantFiled: February 17, 1993Date of Patent: August 15, 2000Assignee: Hyal Pharmaceutical CorporationInventors: Rudolf Edgar Falk, Samuel Simon Asculai, Ehud Shmuel Klein, David William Harper, David Hochman, Don Purschke
-
Patent number: 5990096Abstract: The invention relates to a method of controlling the unloading of a drug from the skin or exposed tissue of a human into the lymphatic system comprising transporting an effective dosage amount of the drug into the skin or exposed tissue by an effective non-toxic amount of a form of hyaluronic acid.Type: GrantFiled: June 6, 1995Date of Patent: November 23, 1999Assignee: Hyal Pharmaceutical CorporationInventors: Samuel Simon Asculai, David Hochman, Don Purschke, David William Harper, Ehud Shmuel Klein, Rudolf Edger Falk
-
Patent number: 5977088Abstract: Pharmaceutical compositions from which effective non-toxic (to the patient) dosage amounts may be taken and applied to the skin and/or exposed tissue of a human, each effective dosage amount comprising pharmaceutical excipients suitable for topical application, an effective non-toxic dosage amount of a drug to treat and to assist to resolve a disease and/or condition of the skin and/or exposed tissue of a human and an effective non-toxic dosage amount of hyaluronic acid and/or salts thereof and/or homologues, analogues, derivatives, complexes, esters, fragments, and/or sub-units of hyaluronic acid sufficient to transport (to facilitate or cause the transport of) the drug, to a site in the skin including epidermis or exposed tissue of a disease or condition for percutaneous transport into the skin and/or exposed tissue to accumulate and remain there for a prolonged period of time and which is systemic independent acting.Type: GrantFiled: June 6, 1995Date of Patent: November 2, 1999Assignee: Hyal Pharmaceutical CorporationInventors: David William Harper, Ehud Shmuel Klein, Rudolf Edger Falk, Samuel Simon Asculai, David Hochman, Don Purschke
-
Patent number: 5942498Abstract: Topically applied transdermally quick penetrating compositions containing a drug and hyaluronic acid and/or salts thereof and methods of treating diseases and conditions employing said compositions.Type: GrantFiled: June 6, 1995Date of Patent: August 24, 1999Assignee: Hyal Pharmaceutical CorporationInventors: Rudolf Edger Falk, Samuel Simon Asculai, Ehud Shmuel Klein, David William Harper, David Hochman, Don Purschke
-
Patent number: 5847002Abstract: The use of:(a) a non-steroidal anti-inflammatory agent,and(b) hyaluronic acid and/or salts thereof and/or homologues, analogues, derivatives, complexes, esters, fragments, and subunits of hyaluronic acid,in the manufacture of a pharmaceutical composition for inhibiting, controlling and/or regressing angiogenesis in a therapy wherein dosage amounts taken from the composition each comprise:(1) a therapeutically effective amount of component (a); and(2) a therapeutically effective amount of the hyaluronic acid and/or salts thereof and/or homologues, analogues, derivatives, complexes, esters, fragments, and sub-units of hyaluronic acid, the pharmaceutical composition being characterized in that for each dosage amount taken from the pharmaceutical composition, the amount of components (a) and (b) inhibit, control and/or regress angiogenesis.Type: GrantFiled: June 5, 1995Date of Patent: December 8, 1998Assignee: Hyal Pharmaceutical CorporationInventors: Derek A. Willoughby, Chandan Alam, Samuel Simon Asculai, Rudolf Edgar Falk, David William Harper